Ousia,Thanks for your comments. ACL did say that the oncology...

Ousia,

Thanks for your comments. ACL did say that the oncology arm would be listed on a "reputable" exchange. That seems an odd statement to make if they are going for the ASX.
It's also an understatement for the NASDAQ. So I was wondering about the London AIM. Does Pete want to go home maybe?

I personally would prefer the NASDAQ, as US investors would see this as another Abraxis, but with the extra cancer stem cell potential.